Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Bulk Density and Tapped Density Method – V 2.0

Posted on By

Analytical Method Development: SOP for Bulk Density and Tapped Density Method – V 2.0

Standard Operating Procedure for Bulk Density and Tapped Density Determination in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/295/2025
Supersedes SOP/AMD/295/2022
Page No. Page 1 of 10
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a validated and standardized procedure for the determination of bulk density and tapped density of powders and granules to assess powder flow

characteristics in formulation development and quality control.

2. Scope

This SOP is applicable to the Analytical Method Development and Quality Control departments involved in the testing of raw materials, intermediates, and finished pharmaceutical powders or granules.

3. Responsibilities

  • QC Analyst: Conducts the test and records results.
  • Analytical Scientist: Reviews and interprets results to support formulation decisions.
  • QA Executive: Ensures compliance with compendial and internal procedures.
See also  Analytical Method Development: SOP for Bridging Study Between Two Analytical Methods - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for implementing and maintaining accurate density testing methods in accordance with USP and ICH guidelines.

5. Procedure

5.1 Apparatus and Materials

  • 100 mL graduated measuring cylinder
  • Tapped density tester (USP Type I or II)
  • Powder funnel
  • Analytical balance (accuracy ±0.001 g)

5.2 Sample Preparation

  1. Accurately weigh about 50 g of powder or granules.
  2. Ensure the sample is free from clumps and moisture.

5.3 Bulk Density Measurement

  1. Gently pour the weighed powder into the 100 mL graduated cylinder through a funnel without compacting the sample.
  2. Record the initial volume (Vb) in mL.
  3. Calculate bulk density using:

    Bulk Density (g/mL) = Weight of sample (g) / Bulk volume (Vb)

5.4 Tapped Density Measurement

  1. Place the cylinder on the tapped density tester and perform 500 taps initially.
  2. Note the volume. If it changes by >2%, tap for an additional 750 times or until stable (max 1250 taps).
  3. Record final volume (Vt).
  4. Calculate tapped density using:

    Tapped Density (g/mL) = Weight of sample (g) / Tapped volume (Vt)
See also  Analytical Method Development: Zeta Potential Determination SOP - V 2.0

5.5 Data Interpretation

  • Calculate Compressibility Index (CI) and Hausner Ratio (HR) as per SOP/AMD/294/2025 if required for flow evaluation.

6. Abbreviations

  • Vb: Bulk Volume
  • Vt: Tapped Volume
  • CI: Compressibility Index
  • HR: Hausner Ratio
  • USP: United States Pharmacopeia

7. Documents

  1. Bulk and Tapped Density Data Sheet – Annexure-1
  2. Instrument Calibration Log – Annexure-2
  3. Test Summary Report – Annexure-3

8. References

  • USP <616>: Bulk Density and Tapped Density of Powders
  • Ph. Eur. 2.9.34: Bulk and Tapped Density
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ramesh Iyer Priya Thakur Sunita Reddy
Designation QC Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Bulk and Tapped Density Data Sheet

Sample ID Weight (g) Bulk Volume (mL) Tapped Volume (mL) Bulk Density Tapped Density
BTD-295-01 50.0 74.0 64.5 0.676 g/mL 0.775 g/mL

Annexure-2: Instrument Calibration Log

Tapped density tester calibrated on 01/04/2025 by Metrology Dept. Calibration certificate No: CAL/295/2025/042

Annexure-3: Test Summary Report

Powder blend tested for bulk and tapped density. Results indicate fair flow with CI = 12.8%, HR = 1.15. Suitable for direct compression.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Clarified tapping procedure and acceptance thresholds Annual SOP Review Sunita Reddy
10/10/2022 1.0 Initial Release New SOP QA Head
See also  Analytical Method Development: SOP for System Suitability Evaluation - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Audit Risk from Unrevised Autoclave SOPs After Cycle Revalidation
Next Post: Rolling Out Revised SOPs: Communication Plans and Training Strategies

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version